• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华法林诱导的深静脉血栓形成。

Warfarin-induced deep vein thrombosis.

作者信息

Binymin Khalid A, Nasher Magda, Patel Dipti

机构信息

Liverpool University, Medical School, England, UK.

Southport and Ormskirk NHS Trust, Southport District General Hospital, Kew, UK.

出版信息

Int Med Case Rep J. 2014 Sep 9;7:123-5. doi: 10.2147/IMCRJ.S62100. eCollection 2014.

DOI:10.2147/IMCRJ.S62100
PMID:25246809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4166964/
Abstract

We are presenting a 72-year-old female who was admitted to hospital with deep vein thrombosis (DVT). She was known to have atrial fibrillation and was initiated on warfarin for stroke prophylaxis 3 days earlier. She was given warfarin therapy without low molecular weight heparin cover as per "slow-start regimen" protocol. The warfarin dose was increased after 3 days to achieve rapid anticoagulation, resulting in DVT in the left leg. We propose that the higher unopposed warfarin dose utilized in this case resulted in DVT. Warfarin loading doses may paradoxically result in a hypercoagulable state and potential clot formation because of significant reductions in protein C and protein S levels.

摘要

我们正在介绍一位72岁的女性患者,她因深静脉血栓形成(DVT)入院。已知她患有心房颤动,3天前开始服用华法林以预防中风。根据“缓慢启动方案”,她接受了华法林治疗,但未使用低分子量肝素覆盖。3天后增加了华法林剂量以实现快速抗凝,结果导致左腿出现深静脉血栓形成。我们认为,本病例中使用的较高剂量的未对抗华法林导致了深静脉血栓形成。由于蛋白C和蛋白S水平显著降低,华法林负荷剂量可能反常地导致高凝状态和潜在的血栓形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e8/4166964/fc6cfd853286/imcrj-7-123Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e8/4166964/fc6cfd853286/imcrj-7-123Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e8/4166964/fc6cfd853286/imcrj-7-123Fig1.jpg

相似文献

1
Warfarin-induced deep vein thrombosis.华法林诱导的深静脉血栓形成。
Int Med Case Rep J. 2014 Sep 9;7:123-5. doi: 10.2147/IMCRJ.S62100. eCollection 2014.
2
Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.低剂量华法林、低分子肝素或对照组预防癌症患者导管相关性深静脉血栓形成:一项随机、对照、III 期研究。
Cancer Chemother Pharmacol. 2013 Jul;72(1):65-73. doi: 10.1007/s00280-013-2169-y. Epub 2013 May 1.
3
A Rare Thrombophilic Occurrence: Dural Venous Sinus Thrombosis in a Patient with Significant Family History of Protein S Deficiency.一例罕见的血栓形成情况:一名有严重蛋白S缺乏家族史的患者发生硬脑膜静脉窦血栓形成。
Cureus. 2021 Mar 13;13(3):e13866. doi: 10.7759/cureus.13866.
4
Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States.一项经济模型的结果,该模型用于评估低分子量肝素依诺肝素与华法林在美国全髋关节置换手术中预防深静脉血栓形成及相关长期并发症的成本效益。
Clin Ther. 2002 Nov;24(11):1960-86; discussion 1938. doi: 10.1016/s0149-2918(02)80091-1.
5
Bilateral Phlegmasia Cerulea Dolens After Warfarin Reversal for Acute Rectal Bleeding: A Case Report.华法林逆转治疗急性直肠出血后双侧股青肿:一例报告
J Emerg Med. 2018 Apr;54(4):533-536. doi: 10.1016/j.jemermed.2017.12.055. Epub 2018 Feb 12.
6
A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation.皮下注射低分子量肝素与华法林钠预防髋或膝关节置换术后深静脉血栓形成的比较。
N Engl J Med. 1993 Nov 4;329(19):1370-6. doi: 10.1056/NEJM199311043291902.
7
A prospective controlled study of the efficacy of short-term anticoagulation therapy in patients with deep vein thrombosis of the lower extremity.一项关于短期抗凝治疗对下肢深静脉血栓形成患者疗效的前瞻性对照研究。
J Vasc Surg. 1998 Oct;28(4):630-7. doi: 10.1016/s0741-5214(98)70087-4.
8
Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.急性髂股深静脉血栓形成导管直接溶栓治疗后的妊娠情况。
Phlebology. 2013 Mar;28 Suppl 1:34-8. doi: 10.1177/0268355513477286.
9
The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement.全髋关节置换术后四周口服抗凝治疗对深静脉血栓形成率的影响。
J Vasc Surg. 1999 Nov;30(5):813-20. doi: 10.1016/s0741-5214(99)70005-4.
10
[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].[全膝关节置换术后低分子肝素与华法林联合抗凝治疗的并发症及风险——我们的经验]
Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44.

引用本文的文献

1
Anticoagulant Overdose With Paradoxical Thrombotic Risk.抗凝药物过量与反常血栓形成风险
Cureus. 2024 Dec 21;16(12):e76116. doi: 10.7759/cureus.76116. eCollection 2024 Dec.
2
Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review.印度基层医疗环境中新型口服抗凝剂用于非瓣膜性心房颤动卒中预防的专家意见:一项文献综述
Cureus. 2022 May 18;14(5):e25102. doi: 10.7759/cureus.25102. eCollection 2022 May.
3
Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network.

本文引用的文献

1
Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.执行摘要:《抗栓治疗与血栓形成预防》第9版:美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):7S-47S. doi: 10.1378/chest.1412S3.
2
Guidelines on oral anticoagulation with warfarin - fourth edition.华法林口服抗凝治疗指南 - 第四版
Br J Haematol. 2011 Aug;154(3):311-24. doi: 10.1111/j.1365-2141.2011.08753.x. Epub 2011 Jun 14.
3
Warfarin-induced skin necrosis associated with Factor V Leiden and protein S deficiency.
预测常用抗凝剂对人体凝血网络影响的定量系统药理学模型
CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):554-564. doi: 10.1002/psp4.12111. Epub 2016 Sep 20.
4
Stent thrombosis caused by metal allergy complicated by protein S deficiency and heparin-induced thrombocytopenia: a case report and review of the literature.金属过敏导致支架血栓形成,合并蛋白 S 缺乏症和肝素诱导的血小板减少症:病例报告及文献复习。
Thromb J. 2015 Jul 23;13:25. doi: 10.1186/s12959-015-0055-z. eCollection 2015.
5
Paradoxical Procoagulant Effect of Early Doses of Warfarin: Possible Role of Non-Vitamin K Oral Anticoagulant in Patients with Atrial Fibrillation-Related Stroke.早期剂量华法林的反常促凝作用:非维生素K口服抗凝剂在房颤相关性卒中患者中的可能作用
J Stroke. 2015 May;17(2):216-8. doi: 10.5853/jos.2015.17.2.216. Epub 2015 May 29.
华法林诱导的皮肤坏死与凝血因子V莱顿突变和蛋白S缺乏相关。
Clin Lab Haematol. 2001 Aug;23(4):261-4. doi: 10.1046/j.1365-2257.2001.00399.x.
4
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology.美国心脏病学会/美国心脏协会/欧洲心脏病学会心房颤动患者管理指南。美国心脏病学会/美国心脏协会实践指南特别工作组和欧洲心脏病学会实践指南与政策会议委员会(制定心房颤动患者管理指南委员会)联合北美心脏起搏与电生理学会制定的报告。
Eur Heart J. 2001 Oct;22(20):1852-923. doi: 10.1053/euhj.2001.2983.
5
Warfarin induced skin necrosis.华法林所致皮肤坏死。
Br J Surg. 2000 Mar;87(3):266-72. doi: 10.1046/j.1365-2168.2000.01352.x.
6
A new regimen for starting warfarin therapy in out-patients.一种用于门诊患者启动华法林治疗的新方案。
Br J Clin Pharmacol. 1998 Aug;46(2):157-61. doi: 10.1046/j.1365-2125.1998.00755.x.
7
A warfarin induction regimen for out-patient anticoagulation in patients with atrial fibrillation.用于心房颤动患者门诊抗凝治疗的华法林诱导方案。
Br J Haematol. 1998 Jun;101(3):450-4. doi: 10.1046/j.1365-2141.1998.00716.x.
8
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.口服抗凝剂。作用机制、临床疗效及最佳治疗范围。
Chest. 1995 Oct;108(4 Suppl):231S-246S. doi: 10.1378/chest.108.4_supplement.231s.
9
A method for estimating the probability of adverse drug reactions.一种估算药物不良反应概率的方法。
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.